Adverum Biotechnologies (formerly known as Avalanche Biotechnologies) is a clinical-stage gene therapy company targeting unmet medical need in ophthalmology and rare diseases.
Geron is a clinical stage biopharmaceutical company focused on the development of a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.
Dermira is a development-stage biotech company focused on developing and commercializing innovative new therapies in dermatology.
Corcept Therapeutics is a pharmaceutical company which discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and psychiatric disorders.
Corium is a commercial-stage biopharmaceutical company leading the development of new transdermal healthcare products.
DNA tests for vision loss risk.
Forty Seven is an immuno-oncology company, which develops therapies that target cancer immune evasion pathways.
Calysta is creating Future Fit Food – high value fish, livestock, and pet nutritional products to improve global food sustainability and security.
Advancing Future Generation Immunotherapies.
Synthomics is driving life science innovation at the most basic level to deliver novel oligonucleotide synthesis solutions directly to genomic providers.
Refuge Biotechnologies is a provider of gene engineering technologies intended to develop therapeutic cells to fight cancer.
BillionToOne is a precision diagnostics company offering a prenatal cystic fibrosis and spinal muscular atrophy screening option.